Last year, synthetic biologist George Church and a team at Harvard’s Wyss Institute combined three different gene therapies related to cellular decay into a single compound to see if it might reverse obesity and diabetes while also improving kidney and heart function. Remarkably, the technique seemed to work—in mice.
This trend is part of our section on Synthetic Biology. Other trends in this section include:
Agriculture, Beauty, Biosciences, Chemical & Related Manufacturing, Covid-19/ coronavirus, Defense, Drug Manufacturers, Education Colleges & Universities, Government - International, Government - National, Government Regulators, Health Professionals, Hedge Funds, Information Technology, Insurance, Lawyers/Law Firms/Legal Industry, Lobbyists, National Security, Non-profits/Foundations/Philanthropists, Pharmaceuticals/Health Products, Private Equity, Technology Company, Venture Capital